Last Modified: May 6, 2010
Conference Dates: July 16-17, 2010
Conference Location: United States
Sponsoring Group: Physicians’ Education Resource
Conference Web Page URL: http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/525
Conference Objectives: A comprehensive review of current therapeutic strategies for the treatment of all stages of kidney, bladder, and prostate cancers, including clinical and molecular disease characterization, prevention, prognostication, multimodality management of disease, and new therapeutic agents.
Who Should Attend: medical, surgical, and radiation oncologists and urologists, Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of genitourinary malignancies are also invited to attend.
Conference Fees: Please see our website for current pricing
Continuing Education: Yes
Jan 30, 2015 - After decades on the increase, the number of U.S. deaths from malignant mesothelioma should peak next year, according to a statistical analysis published in the April 24 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Jan 30, 2015
Mar 5, 2010